|Mr. Jonathan M. Glenn||CEO & Exec. Director||N/A||N/A||1969|
|Mr. Paul Hayes||CFO, Company Sec. & Exec. Director||N/A||N/A||1967|
|Mr. Iain Lindsay||Interim Group Gen. Counsel||N/A||N/A||N/A|
|Ms. Lisa King||Director of HR||N/A||N/A||N/A|
|Dr. Keyvan Djamarani||Managing Director of Bespak||N/A||N/A||N/A|
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.
Consort Medical plc’s ISS Governance QualityScore as of May 1, 2018 is 7. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 1; Compensation: 7.